1. Home
  2. POLE vs VSTM Comparison

POLE vs VSTM Comparison

Compare POLE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POLE
  • VSTM
  • Stock Information
  • Founded
  • POLE 2024
  • VSTM 2010
  • Country
  • POLE United States
  • VSTM United States
  • Employees
  • POLE N/A
  • VSTM N/A
  • Industry
  • POLE
  • VSTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • POLE
  • VSTM Health Care
  • Exchange
  • POLE NYSE
  • VSTM Nasdaq
  • Market Cap
  • POLE 294.2M
  • VSTM 239.9M
  • IPO Year
  • POLE 2024
  • VSTM 2012
  • Fundamental
  • Price
  • POLE $9.98
  • VSTM $3.90
  • Analyst Decision
  • POLE
  • VSTM Strong Buy
  • Analyst Count
  • POLE 0
  • VSTM 8
  • Target Price
  • POLE N/A
  • VSTM $12.00
  • AVG Volume (30 Days)
  • POLE 3.5K
  • VSTM 1.0M
  • Earning Date
  • POLE 01-01-0001
  • VSTM 11-06-2024
  • Dividend Yield
  • POLE N/A
  • VSTM N/A
  • EPS Growth
  • POLE N/A
  • VSTM N/A
  • EPS
  • POLE N/A
  • VSTM N/A
  • Revenue
  • POLE N/A
  • VSTM $10,000,000.00
  • Revenue This Year
  • POLE N/A
  • VSTM N/A
  • Revenue Next Year
  • POLE N/A
  • VSTM $53.90
  • P/E Ratio
  • POLE N/A
  • VSTM N/A
  • Revenue Growth
  • POLE N/A
  • VSTM N/A
  • 52 Week Low
  • POLE $9.94
  • VSTM $2.10
  • 52 Week High
  • POLE $11.05
  • VSTM $14.22
  • Technical
  • Relative Strength Index (RSI)
  • POLE N/A
  • VSTM 40.43
  • Support Level
  • POLE N/A
  • VSTM $4.18
  • Resistance Level
  • POLE N/A
  • VSTM $4.55
  • Average True Range (ATR)
  • POLE 0.00
  • VSTM 0.40
  • MACD
  • POLE 0.00
  • VSTM -0.17
  • Stochastic Oscillator
  • POLE 0.00
  • VSTM 2.71

About POLE ANDRETTI ACQUISITION CORP. II

Andretti Acquisition Corp II is a blank check company.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: